DARECCA JAMES (EVP, Chief Financial Officer) received a stock award from HAEMONETICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/3/2025ACC: 0001127602-25-016517
Officer· EVP, Chief Financial Officer
Since Apr 2022
+6.36K
Net shares
Net buyer
$406.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
12.22K acquired · 5.86K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.22K
Price / share
—
Trade value
—
% of position
55.7%
5/30/2025
21.93K→34.16K
Common Stock
Direct
Shares
−5.86K
Price / share
$69.38
Trade value
$406.84K
% of position
17.2%
5/30/2025
34.16K→28.29K
Total
Net shares
+6.36K
Net value
-$406.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/30/2025 | A · Award | +12.22K | — | — | 55.7% | 21.93K | 34.16K |
| Common Stock Direct | 5/30/2025 | F · Tax Withholding | −5.86K | $69.38 | $406.84K | 17.2% | 34.16K | 28.29K |
| Total | +6.36K | -$406.84K | ||||||
Derivative Transactions0
No derivative transactions reported